Chemical formula: C₇H₆O₃ Molecular mass: 138.121 g/mol PubChem compound: 338
Salicylic acid interacts in the following cases:
Systemically absorbed salicylic acid may enhance the hypoglycemic activity of the sulfonamides, urea derivatives.
Salicylic acid administered at high doses increases the activity of acetazolamide.
Systemically absorbed salicylic acid may increase the toxicity of methotrexate.
Whilst there are no known contra-indications to use of salicylic acid during pregnancy, the safety has not been established. Salicylic acid should therefore be used with caution or following professional advice.
Whilst there are no known contra-indications to use of salicylic acid during actation, the safety has not been established. Salicylic acid should therefore be used with caution or following professional advice.
None known.
Undesirable effects are listed by MedDRA System Organ Classes.
Assessment of undesirable effects is based on the following frequency groupings: Very common ≥1/10, Common ≥1/100 to <1/10, Uncommon ≥1/1,000 to <1/100, Rare ≥1/10,000 to <1/1,000, Very rare <1/10,000, Not known cannot be estimated from the available data.
Not known: skin irritation*
Not known: salicylism (including tinnitus)
* A localised irritant reaction may occur if salicylic acid is applied to normal skin surrounding the wart. This may normally be controlled by temporarily discontinuing the use of salicylic acid and by being careful to apply the solution only to the wart itself when treatment is resumed.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
